Eric Nils Gunnar Wahlberg

Corporate Officer/Principal bei University of Linköping

64 Jahre

Health Technology

Consumer Services

Commercial Services

Profil

Eric Nils Gunnar Wahlberg is currently a Professor of Vascular Surgery at the University of Linköping.
He previously worked as a Director at ClanoTech AB, a Clinical Team Leader at Novartis AG, and a Vice President of Clinical at AstraZeneca UK Ltd.

Aktive Positionen von Eric Nils Gunnar Wahlberg

Unternehmen	Position	Beginn
University of Linköping University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services.	Corporate Officer/Principal	-

Alle aktiven Positionen von Eric Nils Gunnar Wahlberg

Ehemalige bekannte Positionen von Eric Nils Gunnar Wahlberg

Unternehmen	Position	Ende
AstraZeneca UK Ltd. AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.	Corporate Officer/Principal	-
NOVARTIS AG	Corporate Officer/Principal	-
ClanoTech AB ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Eric Nils Gunnar Wahlberg im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Eric Nils Gunnar Wahlberg im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
NOVARTIS AG	Health Technology

Private Unternehmen	2
ClanoTech AB ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden.	Health Technology
AstraZeneca UK Ltd. AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.	Commercial Services